HRAS and neoplasm: Since BRAF is involved in ERK kinase activation in the RAS/RAF/ERK signalling pathway, it will be interesting to further compare the biological behaviour of HRAS and BRAF mutated tumours in order to determine whether they have similar clinical characteristics and to determine if they will fall into the “cluster 2” group of gene expression patterns.